The landscape of cancer genes and mutational processes in breast cancer.

Nature 2012 May 16;486(7403):400-4. Epub 2012 May 16.

Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK.

All cancers carry somatic mutations in their genomes. A subset, known as driver mutations, confer clonal selective advantage on cancer cells and are causally implicated in oncogenesis, and the remainder are passenger mutations. The driver mutations and mutational processes operative in breast cancer have not yet been comprehensively explored. Here we examine the genomes of 100 tumours for somatic copy number changes and mutations in the coding exons of protein-coding genes. The number of somatic mutations varied markedly between individual tumours. We found strong correlations between mutation number, age at which cancer was diagnosed and cancer histological grade, and observed multiple mutational signatures, including one present in about ten per cent of tumours characterized by numerous mutations of cytosine at TpC dinucleotides. Driver mutations were identified in several new cancer genes including AKT2, ARID1B, CASP8, CDKN1B, MAP3K1, MAP3K13, NCOR1, SMARCD1 and TBX3. Among the 100 tumours, we found driver mutations in at least 40 cancer genes and 73 different combinations of mutated cancer genes. The results highlight the substantial genetic diversity underlying this common disease.

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature11017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428862PMC
May 2012
80 Reads
531 Citations
42.351 Impact Factor

Publication Analysis

Top Keywords

driver mutations
16
cancer genes
16
mutations
9
100 tumours
8
cancer
8
breast cancer
8
mutational processes
8
somatic mutations
8
genes
5
histological grade
4
grade observed
4
cancer histological
4
diagnosed cancer
4
cancer diagnosed
4
changes mutations
4
observed multiple
4
multiple mutational
4
cent tumours
4
tumours characterized
4
ten cent
4

References

(Supplied by CrossRef)

MR Stratton et al.
Nature 2009

C Greenman et al.
Genetics 2006

I Varela et al.
Nature 2011

Y Keshet et al.
Methods Mol. Biol. 2010

GH Su et al.
Cancer Res. 1998

JD Carpten et al.
Nature 2007

HS Park et al.
J. Biol. Chem. 2002

A Carnero et al.
Curr. Cancer Drug Targets 2008

GS Wu et al.
Cancer Biol. Ther. 2004

AJ Horlein et al.
Nature 1995

KW Merrell et al.
Oncogene 2010

Similar Publications